Egle Therapeutics Identifies First Novel Regulatory T-cell Targets in Research Alliance with Takeda

Retrieved on: 2020-11-26 10:41:15

Tags for this article:

Click the tags to see associated articles and topics

Egle Therapeutics Identifies First Novel Regulatory T-cell Targets in Research Alliance with Takeda. View article details on hiswai:

Excerpt

Egle Therapeutics SAS (Egle), an emerging <b>biotechnology</b> company focused on developing first-in class immunotherapies targeting immune ...

Article found on: www.valdostadailytimes.com